Bayer: all 1,694 studies
Page 13 of 17. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.
- Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) PatientsCompletedNCT01516840Phase 3
- Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) PatientsCompletedNCT01516814Phase 3
- Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesNo longer availableNCT01516762
- Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium CarbonateCompletedNCT01514851Phase 3
- Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)CompletedNCT01512966Phase 3
- Nexavar as First Targeted Therapy in Patients With Advanced Renal Cell CarcinomaCompletedNCT01508364
- Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple SclerosisCompletedNCT01491100
- Relative Bioavailability and Food Effect StudyCompletedNCT01489488Phase 1
- Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in JapanCompletedNCT01479387
- Hepatocellular Carcinoma Registry for Turkey (3K Trial)CompletedNCT01473121
- Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862CompletedNCT01473108Phase 1
- Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation StudyCompletedNCT01469169Phase 3
- Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT SystemCompletedNCT01468545
- Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common ColdCompletedNCT01465009Phase 4
- Placebo and Active Controlled, Double Dummy Study to Compare Efficacy of Aspirin and Ibuprofen in Treatment of Episodic Tension-type HeadacheCompletedNCT01464983Phase 4
- Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral OriginCompletedNCT01464944Phase 4
- Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced CancerCompletedNCT01460537Phase 1
- Iloprost Therapy in Patients With Critical Limb IschemiaCompletedNCT01458041
- Age and Gender Effects on the Pharmacokinetics of BAY85-3934CompletedNCT01458028Phase 1
- Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat PainCompletedNCT01453400Phase 3
- Study To Assess the Dietary Carbohydrate Content of Indian Diabetic PopulationCompletedNCT01450592
- Non-Persistence/Non-Adherence (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Patients in GermanyCompletedNCT01448538
- Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)CompletedNCT01447043
- Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)CompletedNCT01444586
- Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary InterventionCompletedNCT01442792Phase 2
- Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.CompletedNCT01439152Phase 1
- China Betaferon Adherence, Coping and Nurse Support StudyCompletedNCT01436838
- Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A PatientsCompletedNCT01436825
- Risk of Acute Liver Injury in Users of AntimicrobialsCompletedNCT01434173
- LCS12 Adolescent StudyCompletedNCT01434160Phase 3
- Evaluate Onset of Action of a Fast Release AspirinCompletedNCT01420094Phase 3
- Fosrenol Post-marketing Surveillance for Hemodialysis in JapanCompletedNCT01419327
- Community-Acquired Pneumonia (CAP) SurveillanceCompletedNCT01416506
- Observational Study of Ultravist in Patients Requiring CECTCompletedNCT01415414
- Betaferon® Regulatory Post-Marketing SurveillanceCompletedNCT01414816
- Mirena Post-marketing Surveillance in JapanCompletedNCT01414140
- Nexavar Post-marketing Surveillance for RCC in Japan: Early Access ProgramCompletedNCT01412671
- Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in JapanCompletedNCT01412398
- Primovist Post-marketing Surveillance in JapanCompletedNCT01411449
- Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in JapanCompletedNCT01411436
- Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in JapanCompletedNCT01411423
- Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced CancerCompletedNCT01411410Phase 1
- HPA Axis Study in AdultsCompletedNCT01408511Phase 2
- HPA Axis Study in Japanese AdultsCompletedNCT01407510Phase 2
- Japanese BAY80-6946 Monotherapy Phase I StudyCompletedNCT01404390Phase 1
- Wellnara Post-marketing Surveillance in JapanCompletedNCT01401114
- Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in JapanCompletedNCT01397955
- LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate StudyCompletedNCT01397097Phase 3
- Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life SettingCompletedNCT01392534
- Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Protein Kinase) Inhibitor Refametinib (BAY86-9766) in Patients With Advanced CancerCompletedNCT01392521Phase 1
- Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 YearsCompletedNCT01389271
- A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard TabletCompletedNCT01388153Phase 1
- Julina Post-marketing Surveillance for Climacteric Symptoms in JapanCompletedNCT01386281
- Kogenate FS Regulatory Post-Marketing SurveillanceCompletedNCT01386268
- Magnevist Post-marketing Surveillance in JapanCompletedNCT01376739
- YAZ Post-marketing Surveillance in JapanCompletedNCT01375998
- Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney DiseaseCompletedNCT01363336
- Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common ColdCompletedNCT01361399Phase 3
- Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)CompletedNCT01359787Phase 2
- Efficacy of Ventavis Used in Real-life Setting.CompletedNCT01355380
- High Dose BAYA1040 CR: a Long Term Extension StudyCompletedNCT01355367Phase 3
- Depression and Fatigue in MS Patients Treated With Betaferon.CompletedNCT01354665
- Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED)CompletedNCT01354418Phase 1
- Study to Observe Safety and Efficacy of Nexavar in Treatment of Kidney CancerWithdrawnNCT01353794
- Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, FedCompletedNCT01350609Phase 1
- Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction StudyCompletedNCT01348880Phase 1
- BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney DiseaseCompletedNCT01345656Phase 2
- Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor ActivityCompletedNCT01339104Phase 1
- A Study to Compare Omeprazole Administered as Zegerid® Powder and as Prilosec® Capsule in Healthy Participants (P08050)(CL2010-12)CompletedNCT01337804Phase 1
- Observational Program Neo-Penotran® ForteCompletedNCT01335373
- Clinical Study to Evaluate Safety and Maximum Tolerated Dose of BAY1000394 Given in a 4 Week on / 2 Week Off Schedule in Subjects With Advanced MalignanciesCompletedNCT01335256Phase 1
- Influence of Different Approaches to Dietary Advising on the Effects of Acarbose Treatment in Obese Diabetic Patients Under Real-life SettingCompletedNCT01333774
- Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)CompletedNCT01332942Phase 1
- Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin AmericaWithdrawnNCT01331655Phase 3
- Essure Transvaginal Ultrasound (TVU) StudyCompletedNCT01327105Phase 4
- Effect of Rifampin on the Pharmacokinetics of BAY73-4506CompletedNCT01322438Phase 1
- Effect of Piroxicam on OvulationCompletedNCT01320709Phase 2
- Single Dose Group Stratified Study in Renal Impaired and Healthy Aged and Gender Matched SubjectsCompletedNCT01318551Phase 1
- Effect of Ketoconazole on Regorafenib (BAY73-4506) PharmacokineticsCompletedNCT01318265Phase 1
- Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential HypertensionCompletedNCT01303783Phase 2
- Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced MalignanciesTerminatedNCT01297530Phase 1
- Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)CompletedNCT01295294Phase 4
- High Dose BAYA1040_Nifedipine: a Long Term Combination StudyCompletedNCT01294215Phase 3
- BAY73-4506 Probe Substrate StudyCompletedNCT01287598Phase 1
- High Dose BAYA1040_Nifedipine: a Dose-comparative StudyCompletedNCT01287260Phase 3
- Visanne Study to Assess Safety in AdolescentsCompletedNCT01283724Phase 2
- European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)TerminatedNCT01260870Phase 2
- Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder FunctionCompletedNCT01257984Phase 3
- Combination With Gemcitabine in Advanced Pancreatic CancerCompletedNCT01251640Phase 1/2
- GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal InsulinCompletedNCT01248481
- Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectorsCompletedNCT01235455
- BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus ProgramCompletedNCT01233245
- Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD)CompletedNCT01228513Phase 2
- Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting ConditionsCompletedNCT01227603Phase 1
- GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes PatientsCompletedNCT01219582
- Xirtam H Combination In the Treatment of Hypertension Evaluation Study.CompletedNCT01219556
- COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-i Treatment Due to couGH in SlovakiaCompletedNCT01217879
- Real Life Safety and Efficacy of VardenafilTerminatedNCT01215409
- COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in PolandCompletedNCT01211171
- LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockersCompletedNCT01207947